Want to see LXEO full AI Analyst Report?
Lexeo Therapeutics, Inc. (LXEO) Income Statement
Lexeo Therapeutics, Inc. Income Statement
Last quarter (Q2 2026), Lexeo Therapeutics, Inc.'s total revenue was $0.00. In Q2, Lexeo Therapeutics, Inc.'s net income was $-25.87M. See Lexeo Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 654.00K | $ 1.66M | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 654.00K | $ 1.66M | |
| $ 109.26M | $ 105.77M | $ 68.51M | $ 61.16M | $ 52.29M | |
| Depreciation and Amortization | $ 2.08M | $ 2.00M | $ 1.84M | $ 1.15M | $ 13.00K |
| $ -97.68M | $ -96.19M | $ -64.35M | $ -58.04M | $ -50.61M | |
| $ -109.26M | $ -105.77M | $ -68.51M | $ -60.51M | $ -50.64M | |
| $ 9.30M | $ 7.43M | $ 2.12M | $ 1.23M | $ 15.00K | |
| $ -99.96M | $ -98.33M | $ -66.39M | $ -59.28M | $ -50.62M | |
| $ -99.96M | $ -98.33M | $ -66.39M | $ -59.28M | $ -50.62M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.86 | $ -3.09 | $ -2.49 | $ -2.36 | $ -2.01 |
| Diluted EPS | $ -1.86 | $ -3.09 | $ -2.49 | $ -2.40 | $ -2.01 |
| Weighted Average Shares Outstanding | 53.65M | 31.79M | 26.65M | 25.17M | 25.17M |
| Weighted Average Shares Outstanding (Diluted) | 53.65M | 31.79M | 26.65M | 25.17M | 25.17M |
Currency in USD